Facial nerve enhancement on gadolinium-DTPA in a case with neurosarcoidosis.
In a case of neurosarcoidosis with bilateral facial nerve palsy and hydrocephalus, contrast-enhanced magnetic resonance imaging (MRI) study and angiotensin converting enzyme (ACE) activities in cerebrospinal fluid (CSF) were valuable for the diagnosis and the follow up. Facial nerve lesions were demonstrated on gadolinium-DTPA enhanced MRI. The disappearance of enhancement was concomitant with the amelioration of facial nerve palsy after corticosteroid therapy.
Sugita
M
M
Department of Neurology, Showa General Hospital, Kodaira, Tokyo.
Sano
M
M
Uchigata
M
M
Aruga
T
T
Matsuoka
R
R
D000328:Adult; D003287:Contrast Media; D005154:Facial Nerve / Q000473:pathology*; D005155:Facial Nerve Diseases / Q000134:cerebrospinal fluid / Q000150:complications / Q000175:diagnosis*; D005158:Facial Paralysis / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D005500:Follow-Up Studies; D019786:Gadolinium DTPA; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006849:Hydrocephalus / Q000150:complications / Q000175:diagnosis / Q000601:surgery; D007089:Image Enhancement / Q000379:methods; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D007703:Peptidyl-Dipeptidase A / Q000134:cerebrospinal fluid; D011239:Prednisolone / Q000627:therapeutic use; D012507:Sarcoidosis / Q000134:cerebrospinal fluid / Q000150:complications / Q000175:diagnosis*; D017287:Ventriculoperitoneal Shunt / Q000379:methods
D003287:Contrast Media; D005938:Glucocorticoids; D011239:Prednisolone; D007703:Peptidyl-Dipeptidase A; D019786:Gadolinium DTPA